Paper Details

  1. Home
  2. Paper Details

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Author: CatesChristopher J, DiasSofia, KewKayleigh M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Treatment for chronic obstructive pulmonary disease (COPD) aims to ease symptoms, improve quality of life, and prevent or manage flare-ups. Treatment typically starts with one inhaler, and additional medications are added as needed. Long-acting inhalers are generally preferred over short-acting ones for ongoing or worsening symptoms. While studies have compared different long-acting inhalers to placebo or other treatments, there's a need for research comparing different types of long-acting inhalers to determine which class of medication is most beneficial.
Paper Details　
Original Abstract of the Article :
Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies are introduced as necessary. For persistent or worsening sym...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD010844.pub2

データ提供：米国国立医学図書館（NLM）

Navigating COPD Treatment Options: A Network Meta-Analysis

Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease that affects millions of people worldwide. This research reviews the effectiveness of various long-acting inhaled therapies for managing COPD. The researchers conducted a network meta-analysis, a powerful statistical approach that compares the effectiveness of multiple treatments simultaneously. They found that different classes of inhaled therapies, including beta-agonists, anticholinergics, and steroids, had varying levels of effectiveness in managing COPD symptoms and preventing exacerbations. This study provides valuable insights for clinicians and patients seeking to optimize COPD management.

A Complex Landscape of Therapies

This research underscores the complexity of managing COPD and the need for personalized treatment approaches. The findings suggest that there is no one-size-fits-all solution, and the best treatment option may vary depending on the individual patient's needs and circumstances.

Making Informed Decisions

This research provides a valuable resource for clinicians and patients seeking to make informed decisions about COPD treatment. The study's findings can help guide treatment choices and ensure that patients receive the most effective therapies for their individual needs.

Dr. Camel's Conclusion

This research, like a desert map, guides us through the complex landscape of COPD treatment options. The network meta-analysis reveals the strengths and weaknesses of different inhaled therapies, empowering clinicians and patients to make informed decisions and optimize COPD management.

Date :
  1. Date Completed 2014-09-30
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

24671923

DOI: Digital Object Identifier

10.1002/14651858.CD010844.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.